Is Xvivo Perfusion AB (publ) stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Xvivo Perfusion AB (publ) 10 years ago, but if you had invested on Monday 21st of October 2019 when the price was SEK155.00, you would have made a profit of SEK346.00 per share or 223.23%
Yes, the average daily trading liquidity for Xvivo Perfusion AB (publ) is SEK31 959 thousand. You should therefore be able to get in and out of your positions relatively fast.
Xvivo Perfusion AB (publ) has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 2.55, the company's ability to pay off the debt is good. Xvivo Perfusion AB (publ) has a good net profit margin of 17.28% and should have high tolerances against inflation.
We have calculated the inflation risk for Xvivo Perfusion AB (publ) to be low [0.1 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.